Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,025
Total Claims
$540K
Drug Cost
142
Beneficiaries
$3,805
Cost/Patient
Risk Score Breakdown 4/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
-6%
Cost per patient vs peers
$3,805 vs $4,034 avg
+321%
Brand preference vs peers
39.6% vs 9.4% avg
Brand vs Generic
Brand: 406 claims · $520K
Generic: 619 claims · $20K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rimegepant Sulfate | 96 | $177K |
| Atogepant | 106 | $119K |
| Ubrogepant | 67 | $97K |
| Erenumab-Aooe | 48 | $51K |
| Galcanezumab-Gnlm | 45 | $38K |
| Fremanezumab-Vfrm | 15 | $11K |
| Ergotamine Tartrate/Caffeine | 12 | $3,416 |
| Butalb/Acetaminophen/Caffeine | 56 | $1,750 |
| Rizatriptan Benzoate | 42 | $1,196 |
| Duloxetine Hcl | 42 | $1,070 |
| Topiramate | 36 | $984 |
| Gabapentin | 81 | $777 |
| Sumatriptan Succinate | 52 | $602 |
| Divalproex Sodium | 14 | $415 |
| Venlafaxine Hcl | 17 | $352 |
Prescribing Profile
20
Unique Drugs
4.0
Anomaly Score
Patient Profile
63
Avg Age
77%
Female
1.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About